首页> 美国卫生研究院文献>other >Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma

【2h】

Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma

机译：的apo2L / TRaIL抑制肿瘤生长和骨破坏的多发性骨髓瘤小鼠模型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeMultiple myeloma is an incurable disease, for which the development of new therapeutic approaches is required. Here, we report on the efficacy of recombinant soluble Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to inhibit tumor progression and bone destruction in a xenogeneic model of human multiple myeloma.

著录项

期刊名称 other
作者
Agatha Labrinidis; Peter Diamond; Sally Martin; Shelley Hay; Vasilios Liapis; Irene Zinonos; Natalie A. Sims; Gerald J. Atkins; Cristina Vincent; Vladimir Ponomarev; David M. Findlay; Andrew C.W. Zannettino; Andreas Evdokiou;
展开▼
作者单位

展开▼
年(卷),期 -1(15),6
年度 -1
页码 1998–2009
总页数 27
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma. [J] . Labrinidis A, Diamond P, Martin S, Clinical cancer research: an official journal of the American Association for Cancer Research . 2009,第6期

机译：在多发性骨髓瘤的鼠模型中，Apo2L / TRAIL抑制肿瘤生长和骨破坏。
2. Modulation of eIF5A expression using SNS01 nanoparticles inhibits NF-κB activity and tumor growth in murine models of multiple myeloma [J] . TaylorC.A., LiuZ., TangT.C., Molecular therapy: the journal of the American Society of Gene Therapy . 2012,第7期

机译：使用SNS01纳米粒子调节eIF5A表达可抑制多发性骨髓瘤小鼠模型中的NF-κB活性和肿瘤生长
3. The Role of OPG/TRAIL Complex in Multiple Myeloma: The OPG/TRAIL Complex in an In Vitro Osteoclastogenesis Model Derived From Human Multiple Myeloma-Bone Disease [J] . GIACOMINA BRUNETTI, SILVIA COLUCCI, RITA RIZZI, Annals of the New York Academy of Sciences . 2006,第Apr期

机译：OPG / TRAIL复合体在多发性骨髓瘤中的作用：OPG / TRAIL复合体在源自人多发性骨髓瘤-骨疾病的体外成骨细胞生成模型中
4. α_vβ_3 INTEGRIN-TARGETED LIPOSOMES CONTAINING DOXORUBICIN INHIBIT TUMOR GROWTH AND ANGIOGENESIS IN A SYNGENEIC MURINE MELANOMA MODEL [C] . Charles A. Wartchow, Neal E. DeChene, S. Narasimhan Danthi, Proceedings of the 29th Annual Meeting of the Controlled Release Society . 2002

机译：含阿霉素抑制肿瘤生长和血管生成的α_vβ_3整合素靶向脂质体在共性鼠黑素瘤模型中的应用
5. Determination of the Biological Significances of Platelet Factor 4 (PF4), a Tumor Suppressor Gene Encoding an Angiogenesis Inhibitor in Multiple Myeloma. [D] . Liang, Pei. 2012

机译：确定血小板因子4（PF4）的生物学意义，PF4是编码多发性骨髓瘤中血管生成抑制剂的肿瘤抑制基因。
6. Modulation of eIF5A Expression Using SNS01 Nanoparticles Inhibits NF-κB Activity and Tumor Growth in Murine Models of Multiple Myeloma [O] . Catherine A Taylor, Zhongda Liu, Terence C Tang, 2012

机译：使用SNS01纳米粒子调节eIF5A表达抑制多发性骨髓瘤小鼠模型中的NF-κB活性和肿瘤生长。
7. Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma [O] . Labrinidis, A., Diamond, P., Martin, S., 2009

机译：apo2L / TRaIL在多发性骨髓瘤的鼠模型中抑制肿瘤生长和骨破坏

Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅